Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

The research identifies two genetic variants that increase the risk of developing Endometriosis, a common gynaecological disease and provides clues to the origin of this often very painful condition, which has a significant impact on the quality of life of sufferers.

The research identifies two genetic variants that increase the risk of developing Endometriosis © Shutterstock
The research identifies two genetic variants that increase the risk of developing Endometriosis

Research carried out at the Nuffield Department of Obstetrics & Gynaecology and the Wellcome Trust Centre for Human Genetics, University of Oxford; the Queensland Institute of Medical Research, Australia, and Brigham; and Women's Hospital and Harvard Medical School, Boston, USA, are published in the journal Nature Genetics.

The research identifies two genetic variants that increase the risk of developing Endometriosis, a common gynaecological disease and provides clues to the origin of this often very painful condition, which has a significant impact on the quality of life of sufferers. The study was funded by a grant from the Wellcome Trust as part of the Wellcome Trust Case Control Consortium 2, and builds on 15 years of collaborative work on the genetics of endometriosis between the research groups.

To see the full press release please click here.

For further articles related to the research:

WebMd.Boots.com 12 December:  www.webmd.boots.com/women/news/20101211/endometriosis-genetic-variants-linked-to-increased-risk

BBC News Online 13 December:  www.bbc.co.uk/news/health-11969075

Daily Mail Online 13 December:  www.dailymail.co.uk/health/article-1338071/scan-detects-womb-cancer-symptoms-appear.html

University of Oxford 13 December:  www.ox.ac.uk/media/news_stories/2010/101312_1.html

Wellcome Trust 13 December:  www.wellcome.ac.uk/News/Media-office/Press-releases/2010/WTX063800.htm

Emax health 13 December:  www.emaxhealth.com/1275/add-genetic-variants-risk-factors-endometriosis

The Med Guru 13 December:  www.themedguru.com/20101213/newsfeature/researchers-identify-gene-variants-linked-endometriosis-study-86142730.html

Similar stories

Oxford's largest ever study into Varicose veins shows need for surgery is linked to genetics

Varicose veins are a very common manifestation of chronic venous disease, affecting over 30% of the population in Western countries. In America, chronic venous disease affects over 11 million men and 22 million women aged 40–80 years old. Left untreated it can escalate to multiple health complications including leg ulcers and ultimately amputations. A new international study by Oxford researchers published on 2nd June 2022 in Nature Communications establishes for the first time, a critical genetic risk score to predict the likelihood of patients suffering with Varicose veins to require surgery, as well as pointing the way towards potential new therapies.

New imaging study could make diagnosing endometriosis quicker, more accurate and reduce the need for invasive surgery.

A new research study launches to investigate whether a 20-minute imaging scan can detect the most common types of endometriosis, which currently require surgery to diagnose.

Oxford researchers part of major UK initiative to understand chronic pain

Oxford pain researchers are playing a major role in a new multi-million pound research programme launched by a consortium of funders, including UKRI, Versus Arthritis, Eli Lilly and the Medical Research Foundation.

Endometriosis: pandemic backlog risks making it even harder for women to get help

The COVID-19 pandemic has had a disproportionate and devastating impact on women’s health, according to a report from the Royal College of Obstetricians and Gynaecologists.

Diagnostic test could offer new hope for ME/CFS patients

Myalgic Encephalomyelitis /Chronic Fatigue Syndrome (ME/CFS) is a chronic condition without a diagnostic test and some 80 - 90% of patients remain un-diagnosed. A new paper published in Frontiers in Medicine outlines how having a diagnostic test could greatly help both patients and medics.

MitOX 2022- 8th April

The Nuffield Department of Women's & Reproductive Health invites you to MitOX 2022 on Friday 8th April. Our annual conference for researchers with an interest in mitochondria from academia and pharma. This year's event will be 'hybrid', so you can join in-person or virtually!